Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
about
Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug.Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentMelatonin in Alzheimer's disease and other neurodegenerative disordersProtecting the melatonin rhythm through circadian healthy light exposureCircadian Rhythm and Sleep Disruption: Causes, Metabolic Consequences, and CountermeasuresConstant illumination reduces circulating melatonin and impairs immune function in the cricket Teleogryllus commodus.Melatonin metabolism in the central nervous system.ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation.Antioxidants reduce consequences of radiation exposure.Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?Vesicular melatonin efficiently downregulates sodium fluoride-induced rat hepato- and broncho-TNF-α, TGF-β expressions, and associated oxidative injury: a comparative study of liposomal and nanoencapsulated forms.Potential Use of Chemoprotectants against the Toxic Effects of Cyanotoxins: A Review.Oxidative stress as a crucial factor in liver diseases.Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Melatonin, noncoding RNAs, messenger RNA stability and epigenetics--evidence, hints, gaps and perspectives.Melatonin in mitochondrial dysfunction and related disordersSecretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia.Melatonin: a possible link between the presence of artificial light at night and reductions in biological fitness.Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatoninMelatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Melatonin Reduces Cataract Formation and Aldose Reductase Activity in Lenses of Streptozotocin-induced Diabetic Rat.A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.Folic acid and melatonin ameliorate carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats.Inhibition of endotoxin-induced hepatotoxicity by melatonin in ratsMelatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction.Does melatonin homeostasis play a role in continuous epigastric pain syndrome?Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras.Effects of melatonin and dexpanthenol on antioxidant parameters when combined with estrogen treatment in ovariectomized ratsUrinary 6-sulphatoxymelatonin levels in patients with senile cataracts.Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.Urinary melatonin levels and skin malignancy.Melatonin modulates the expression of BCL-xl and improve the development of vitrified embryos obtained by IVF in mice.The role of mitochondria in brain aging and the effects of melatonin.Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes.Melatonin As A Therapeutic Resource For Inflammatory Visual Diseases.Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands.Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage.
P2860
Q24815611-55C3948B-9F0A-4B71-8B20-0B950BADBA7EQ26766128-1755BBC7-248B-4263-97C7-71487D6F29F7Q28217483-A05825AF-1F11-4D9A-8E28-5FFBE59CAC90Q28385442-60B9F940-577A-4439-AD95-DF43A22A0116Q28396073-30419FBD-C06B-41A8-87FF-9341899DB859Q30403529-AE96C512-8AD3-4E7C-BC61-285CD0F788F2Q30476606-6DDDB5F4-E64A-4C6A-9731-6615563271D4Q33409045-8EF7EDB4-4333-4924-BDA2-C15C4855394CQ33565586-AEFBE581-AB3D-4C39-967B-B51F0EB12C58Q33723452-D475A874-4004-44CE-8C85-3A249ADD7534Q33758442-DECC372C-4084-4687-99B8-CA05D8462A54Q33845108-1887647D-0C84-409D-8D35-7218B6B90BADQ33845484-42A6D991-7983-4EDC-91BE-E3F7ECD67944Q34029266-F9148544-F3C2-4BBF-83E3-3B0D061966A4Q34416921-43F24E02-99E7-468D-8C26-6DEF308F8DD7Q34486777-91A79F2C-4AC1-4C1D-AA0C-03D0D4DD8B7CQ35001051-0364FB5A-572C-4E39-957E-BC6C45C38049Q35033806-2246101A-31C5-4918-9B76-B202E54EB9FDQ35221246-D7C3A6B6-3C00-42F8-B1D5-5E0894F5D726Q35858998-CB176161-E9E6-43F2-8616-408CC7DB4DBEQ36040915-A99D5B58-C1D5-49C5-BA91-03E5999CB527Q36065544-ED55D1CE-0B57-4DDF-ABEF-41FC5896778AQ36246438-F7FD8B1D-EADE-4550-B63E-E9B2ADCEFA76Q36604345-4E0638E7-57F2-465E-BC29-1197FC534A02Q36735399-6A067663-BCC5-483F-B877-950346AE88D2Q36772909-11AFD74A-F601-4697-B509-085B7534165FQ36790442-624581EC-A414-4C7B-B4D8-E4948CE60A80Q37007371-8FEBD97E-563A-4A0F-BF38-3EA5C3B4745AQ37088995-D9A6CBEC-FED6-47EE-965C-E2F854DB99DBQ37300651-AAFD185D-ED5E-41AE-B65B-5A1943E0554DQ37308360-C25349D4-6461-4BBC-9FD9-1121A6D921DAQ37315390-FD388281-11B9-4DB8-BA32-205545BFA1D2Q37494101-1ED26BE9-7304-4659-A573-498962E7C414Q37671814-FE3DC64D-53F7-4929-BDAA-D8D3E0B734CDQ37848076-71B9F976-3AC0-4381-B798-A4BC0973B438Q38885201-F0CEC37C-0E33-426D-8D61-7630A8E3A61BQ38990979-518972F3-7386-4E8B-82E1-DFF7526BD544Q39089092-45EB1279-C147-4376-96EE-6112EACA73B7Q39128977-978A702E-8A9D-4CBE-B038-049A6FD7BAACQ39317854-6D90AE6B-EC0E-4BCA-95BE-5F425AF27A50
P2860
Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Melatonin as an antioxidant: b ...... ogical implications in humans.
@ast
Melatonin as an antioxidant: b ...... ogical implications in humans.
@en
type
label
Melatonin as an antioxidant: b ...... ogical implications in humans.
@ast
Melatonin as an antioxidant: b ...... ogical implications in humans.
@en
prefLabel
Melatonin as an antioxidant: b ...... ogical implications in humans.
@ast
Melatonin as an antioxidant: b ...... ogical implications in humans.
@en
P2093
P1476
Melatonin as an antioxidant: b ...... ogical implications in humans.
@en
P2093
Josefa Leon
Juan C Mayo
Rosa M Sainz
Zbigniew Czarnocki
P304
P577
2003-01-01T00:00:00Z